Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinlu Dai

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
In Vivo (Athens, Greece)|February 2, 2011
ALDH activity indicates increased tumorigenic cells, but not cancer stem cells, in prostate cancer cell linesChunyan Yu, Zhi Yao, Jinlu Dai, et al.
Cancer Research|May 27, 2010
Reversal of chemotherapy-induced leukopenia using granulocyte macrophage colony-stimulating factor promotes bone metastasis that can be blocked with osteoclast inhibitorsJinlu Dai, Yi Lu, Chunyan Yu, et al.
Molecular Cancer Research : MCR|June 10, 2020
Single-Cell Transcriptomics Analysis Identifies Nuclear Protein 1 as a Regulator of Docetaxel Resistance in Prostate Cancer CellsPatricia M Schnepp, Greg Shelley, Jinlu Dai, et al.
Chinese Journal of Cancer|March 16, 2017
Immune mediators in the tumor microenvironment of prostate cancerJinlu Dai, Yi Lu, Hernan Roca, et al.
Molecular Cancer Research : MCR|January 15, 2017
Bone Microenvironment Changes in Latexin Expression Promote ChemoresistanceMi Zhang, Mary Osisami, Jinlu Dai, et al.
Journal of Cellular Biochemistry|October 24, 2007
New trends in the treatment of bone metastasisEvan T Keller, Jinlu Dai, June Escara-Wilke, et al.
Chinese Journal of Cancer|March 31, 2017
Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signalingWenchu Wang, Lihui Wang, Atsushi Mizokami, et al.
BMC Cancer|December 9, 2021
Transcription factor network analysis based on single cell RNA-seq identifies that Trichostatin-a reverses docetaxel resistance in prostate CancerPatricia M Schnepp, Aqila Ahmed, June Escara-Wilke, et al.
Endocrine-Related Cancer|July 18, 2009
Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosteroneAtsushi Mizokami, Eitetsu Koh, Kouji Izumi, et al.
The Prostate|September 3, 2009
CTEN/tensin 4 expression induces sensitivity to paclitaxel in prostate cancerYouQiang Li, Atsushi Mizokami, Kouji Izumi, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
In Vivo (Athens, Greece)|February 2, 2011
ALDH activity indicates increased tumorigenic cells, but not cancer stem cells, in prostate cancer cell linesChunyan Yu, Zhi Yao, Jinlu Dai, et al.
Cancer Research|May 27, 2010
Reversal of chemotherapy-induced leukopenia using granulocyte macrophage colony-stimulating factor promotes bone metastasis that can be blocked with osteoclast inhibitorsJinlu Dai, Yi Lu, Chunyan Yu, et al.
Molecular Cancer Research : MCR|June 10, 2020
Single-Cell Transcriptomics Analysis Identifies Nuclear Protein 1 as a Regulator of Docetaxel Resistance in Prostate Cancer CellsPatricia M Schnepp, Greg Shelley, Jinlu Dai, et al.
Chinese Journal of Cancer|March 16, 2017
Immune mediators in the tumor microenvironment of prostate cancerJinlu Dai, Yi Lu, Hernan Roca, et al.
Molecular Cancer Research : MCR|January 15, 2017
Bone Microenvironment Changes in Latexin Expression Promote ChemoresistanceMi Zhang, Mary Osisami, Jinlu Dai, et al.
Journal of Cellular Biochemistry|October 24, 2007
New trends in the treatment of bone metastasisEvan T Keller, Jinlu Dai, June Escara-Wilke, et al.
Chinese Journal of Cancer|March 31, 2017
Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signalingWenchu Wang, Lihui Wang, Atsushi Mizokami, et al.
BMC Cancer|December 9, 2021
Transcription factor network analysis based on single cell RNA-seq identifies that Trichostatin-a reverses docetaxel resistance in prostate CancerPatricia M Schnepp, Aqila Ahmed, June Escara-Wilke, et al.
Endocrine-Related Cancer|July 18, 2009
Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosteroneAtsushi Mizokami, Eitetsu Koh, Kouji Izumi, et al.
The Prostate|September 3, 2009
CTEN/tensin 4 expression induces sensitivity to paclitaxel in prostate cancerYouQiang Li, Atsushi Mizokami, Kouji Izumi, et al.
Pageof 6